These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
279 related articles for article (PubMed ID: 29848339)
1. rs4889 polymorphism in KISS1 gene, its effect on polycystic ovary syndrome development and anthropometric and hormonal parameters in Saudi women. Albalawi FS; Daghestani MH; Daghestani MH; Eldali A; Warsy AS J Biomed Sci; 2018 May; 25(1):50. PubMed ID: 29848339 [TBL] [Abstract][Full Text] [Related]
2. Influence of KISS1 gene polymorphisms on the risk of polycystic ovary syndrome and its associated variables, in Saudi women. Daghestani MH; Daghestani MH; Daghistani M; Ambreen K; Albalawi FS; AlNeghery LM; Warsy AS BMC Endocr Disord; 2020 May; 20(1):59. PubMed ID: 32380991 [TBL] [Abstract][Full Text] [Related]
3. Association of Kiss1 and GPR54 Gene Polymorphisms with Polycystic Ovary Syndrome among Sri Lankan Women. Branavan U; Muneeswaran K; Wijesundera WSS; Senanayake A; Chandrasekharan NV; Wijeyaratne CN Biomed Res Int; 2019; 2019():6235680. PubMed ID: 30993114 [TBL] [Abstract][Full Text] [Related]
4. Adverse Effects of Selected Markers on the Metabolic and Endocrine Profiles of Obese Women With and Without PCOS. Daghestani MH; Daghestani MH; Warsy A; El-Ansary A; Omair MA; Omair MA; Hassen LM; Alhumaidhi EM; Al Qahtani B; Harrath AH Front Endocrinol (Lausanne); 2021; 12():665446. PubMed ID: 34122339 [TBL] [Abstract][Full Text] [Related]
5. Kisspeptin treatment induces gonadotropic responses and rescues ovulation in a subset of preclinical models and women with polycystic ovary syndrome. Romero-Ruiz A; Skorupskaite K; Gaytan F; Torres E; Perdices-Lopez C; Mannaerts BM; Qi S; Leon S; Manfredi-Lozano M; Lopez-Rodriguez C; Avendaño MS; Sanchez-Garrido MA; Vazquez MJ; Pinilla L; van Duin M; Kohout TA; Anderson RA; Tena-Sempere M Hum Reprod; 2019 Dec; 34(12):2495-2512. PubMed ID: 31820802 [TBL] [Abstract][Full Text] [Related]
6. Metastin levels in relation with hormonal and metabolic profile in patients with polycystic ovary syndrome. Yilmaz SA; Kerimoglu OS; Pekin AT; Incesu F; Dogan NU; Celik C; Unlu A Eur J Obstet Gynecol Reprod Biol; 2014 Sep; 180():56-60. PubMed ID: 25020276 [TBL] [Abstract][Full Text] [Related]
7. Associations of the KiSS-1 and GPR54 genetic polymorphism with polycystic ovary syndrome in Yunnan, China. Zhao T; Zhang Q; Xiao X; Tao X; Gao M; He W; Wu X; Yuan T Gynecol Endocrinol; 2022 Sep; 38(9):790-794. PubMed ID: 35903815 [TBL] [Abstract][Full Text] [Related]
8. Follicle Stimulating Hormone (LH: FSH) Ratio in Polycystic Ovary Syndrome (PCOS) - Obese vs. Non- Obese Women. Saadia Z Med Arch; 2020 Aug; 74(4):289-293. PubMed ID: 33041447 [TBL] [Abstract][Full Text] [Related]
9. Relevance of Daghestani MH; Daghestani MH; Daghistani M; Ambreen K; Almuammar MN; Al Neghery LM; Warsy AS Br J Biomed Sci; 2020 Oct; 77(4):185-190. PubMed ID: 32031919 [No Abstract] [Full Text] [Related]
10. The role of kisspeptin in the pathogenesis of a polycystic ovary syndrome. Aasif A; Alam R; Ahsan H; Khan MM; Khan A; Khan S Endocr Regul; 2023 Jan; 57(1):292-303. PubMed ID: 38127687 [TBL] [Abstract][Full Text] [Related]
11. Role of kisspeptin in polycystic ovary syndrome (PCOS). Emekci Ozay O; Ozay AC; Acar B; Cagliyan E; Seçil M; Küme T Gynecol Endocrinol; 2016 Sep; 32(9):718-722. PubMed ID: 27003383 [TBL] [Abstract][Full Text] [Related]
12. Correlation between kisspeptin and biochemical markers in obese and non-obese women with polycystic ovary syndrome. Gao M; Tao X; Zhang Q; He W; Zhao T; Yuan T Gynecol Endocrinol; 2023 Dec; 39(1):2215869. PubMed ID: 37236245 [No Abstract] [Full Text] [Related]
13. Association of adiponectin and resistin gene polymorphisms in South Indian women with polycystic ovary syndrome. Nambiar V; Vijesh VV; Lakshmanan P; Sukumaran S; Suganthi R Eur J Obstet Gynecol Reprod Biol; 2016 May; 200():82-8. PubMed ID: 26995146 [TBL] [Abstract][Full Text] [Related]
14. Kisspeptin Variations in Patients with Polycystic Ovary Syndrome-A Prospective Case Control Study. Akad M; Socolov R; Furnică C; Covali R; Stan CD; Crauciuc E; Pavaleanu I Medicina (Kaunas); 2022 Jun; 58(6):. PubMed ID: 35744039 [No Abstract] [Full Text] [Related]
15. An association between fat mass and obesity-associated (FTO) (rs9939609) and kisspeptin-1 (KISS-1) (rs4889, rs372790354) gene polymorphisms with polycystic ovary syndrome: an updated meta-analysis and power analysis. Stephen SB; Pauline R; Velmurugan S; Subbaraj GK J Assist Reprod Genet; 2024 Sep; 41(9):2457-2475. PubMed ID: 39126595 [TBL] [Abstract][Full Text] [Related]
16. Is there a role for kisspeptin in pathogenesis of polycystic ovary syndrome? Gorkem U; Togrul C; Arslan E; Sargin Oruc A; Buyukkayaci Duman N Gynecol Endocrinol; 2018 Feb; 34(2):157-160. PubMed ID: 28933574 [TBL] [Abstract][Full Text] [Related]
17. Free testosterone, luteinizing hormone/follicle stimulating hormone ratio and pelvic sonography in relation to skin manifestations in patients with polycystic ovary syndrome. Sharquie KE; Al-Bayatti AA; Al-Ajeel AI; Al-Bahar AJ; Al-Nuaimy AA Saudi Med J; 2007 Jul; 28(7):1039-43. PubMed ID: 17603706 [TBL] [Abstract][Full Text] [Related]
19. Effects of kisspeptin on pathogenesis and energy metabolism in polycystic ovarian syndrome (PCOS). Wang T; Han S; Tian W; Zhao M; Zhang H Gynecol Endocrinol; 2019 Sep; 35(9):807-810. PubMed ID: 30957568 [TBL] [Abstract][Full Text] [Related]
20. Body mass index and gonadotropin hormones (LH & FSH) associate with clinical symptoms among women with polycystic ovary syndrome. Esmaeilzadeh S; Andarieh MG; Ghadimi R; Delavar MA Glob J Health Sci; 2014 Sep; 7(2):101-6. PubMed ID: 25716399 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]